Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy

This study has been completed.
William Marsh Rice University
Information provided by (Responsible Party):
Duke University Identifier:
First received: August 13, 2008
Last updated: May 8, 2015
Last verified: April 2015
The objective of the proposed research is to develop new diagnostic modalities based on optical spectroscopy (auto fluorescence, absorption, and scattering) for the diagnosis of breast cancer and test its performance as an adjunct to core needle biopsy. For the surgery part of the study, all patients scheduled to have a mastectomy or lumpectomy for the treatment of breast cancer will be asked if they would be willing to participate in this study. For the core needle biopsy part of the study, patients with a higher pre-probability of cancer (based on mammography) will be recruited to increase the number of patients with malignant lesions and enrolled in this investigation.

Condition Intervention
Breast Cancer
Device: High Resolution Microendoscope
Device: Bench-top optical spectrometer

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy

Resource links provided by NLM:

Further study details as provided by Duke University:

Primary Outcome Measures:
  • Optical signatures [ Time Frame: Day of procedure (less than 10 minutes) ] [ Designated as safety issue: No ]
    The primary outcome of this study is the identification of the optical signatures of normal and cancerous tissue of the breast

Enrollment: 132
Study Start Date: January 2006
Study Completion Date: December 2014
Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Core needle biopsy
Patients needing a needle biopsy of a breast mass
Device: High Resolution Microendoscope Device: Bench-top optical spectrometer


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Patients having a needle biopsy of a breast mass

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00734838

United States, North Carolina
Duke University Medical Center
Durham, North Carolina, United States, 27708
Sponsors and Collaborators
Duke University
William Marsh Rice University
Principal Investigator: Nimmi Ramanujam, PhD Duke University
  More Information

Responsible Party: Duke University Identifier: NCT00734838     History of Changes
Other Study ID Numbers: Pro00008003  NIH 5R01-CA-100559  W81XWH-09-1-0410 
Study First Received: August 13, 2008
Last Updated: May 8, 2015
Health Authority: United States: Institutional Review Board

Keywords provided by Duke University:
Breast Cancer
Breast Biopsy
Simple Mastectomy
Partial Mastectomy

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases processed this record on December 09, 2016